Immunovant
- Active openings
- 0
- US-based roles
- 0
- Remote-friendly
- 0
- Last updated
- None
What Immunovant is hiring for
About Immunovant
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)